New Frontiers meeting 2020

ECNP has decided that the third New Frontiers in Digital Health Meeting will be a virtual meeting.

About the meeting
This meeting has become an essential platform for focused, high-level exchange at the intersection of research science and new treatment development.

The topics that will be discussed are:

  • Digital therapeutics – a false dawn or a real option for patients?
  • How do we gain regulatory approval for a digital biomarker or therapeutic?
  • Optimising clinical trials with digital tools – pitfalls and promises

This meeting is designed for all representatives from IT, pharma and medical devices industry, regulators, and patient and family associations who are interested to discuss different points of view on how digital health is going to change the way clinical trials are run and the use of digital therapeutics for brain disorders.

New Frontiers Concept

Neuroscience is facing a crisis in the translation of fundamental advances into new treatments. The crisis has seen a significant slowing-down in the development of new and better therapies, and widespread disinvestment from the field, especially in Europe. The ECNP New Frontiers Meeting was launched to help tackle this critical challenge. As Europe’s leading independent scientific association for the science and treatment of disorders of the brain, ECNP is in a unique position to provide a neutral, precompetitive platform for the exchange of insights and ideas across the spectrum of CNS research and development.

Previous meetings

Programme and report of the previous ECNP New Frontiers in Digital Health Meetings can be found here:

Meeting 2020 (cancelled due to corona crisis)

Meeting 2019

Meeting 2018